Results for tag: "Atrasentan"

Atrasentan is a drug used in the treatment of oncology, specifically for the treatment of advanced renal cell carcinoma (RCC). It is a selective endothelin receptor antagonist (ERA) that works by blocking the action of endothelin, a hormone-like substance that can cause the growth of cancer cells. Atrasentan is used in combination with other drugs to reduce the risk of disease progression and improve overall survival. It is also used to reduce the risk of developing new tumors in patients with advanced RCC. Atrasentan is available in both oral and intravenous formulations. It is approved for use in the United States, Europe, and other countries. The drug is marketed by several pharmaceutical companies, including AbbVie, Astellas Pharma, and Daiichi Sankyo. Show Less Read more